TY - JOUR
T1 - Mannose supplementation corrects GDP-mannose deficiency in cultured fibroblasts from some patients with congenital disorders of glycosylation (CDG)
AU - Rush, Jeffrey S.
AU - Panneerselvam, K.
AU - Waechter, Charles J.
AU - Freeze, Hudson H.
PY - 2000
Y1 - 2000
N2 - Congenital Disorders of Glycosylation (CDG) are human deficiencies in glycoprotein biosynthesis. Previous studies showed that 1 mM mannose corrects defective protein N-glycosylation in cultured fibroblasts from some CDG patients. We hypothesized that these CDG cells have limited GDP-mannose (GDP-Man) and that exogenous mannose increases the GDP-Man levels. Using a well established method to measure GDP-Man, we found that normal fibroblasts had an average of 23.5 pmol GDP-Man/106 cells, whereas phosphomannomutase (PMM)-deficient fibroblasts had only 2.3-2.7 pmol/106 cells. Adding 1 mM mannose to the culture medium increased the GDP-Man level in PMM-deficient cells to approximately 15.5 pmol/106 cells, but had no significant effect on GDP-Man levels in normal fibroblasts. Similarly, mannose supplementation increased GDP-Man from 4.6 pmol/106 cells to 24.6 pmol/106 cells in phosphomannose isomerase (PMI)-deficient fibroblasts. Based on the specific activity of the GDP-[3H]Man pool present in [2-3H]mannose labeled cells, mannose supplementation also partially corrected the impaired synthesis of mannosylphosphoryldolichol (Man-P-Dol) and Glc0-3Man9GlcNAc2-P-P-Dol. These results confirm directly that deficiencies in PMM and PMI result in lowered cellular GDP-Man levels that are corrected by the addition of mannose. In contrast to these results, GDP-Man levels in fibroblasts from a CDG-Ie patient, who is deficient in Man-P-Dol synthase, were normal and unaffected by mannose supplementation even though mannose addition was found to correct abnormal lipid intermediate synthesis in another study (Kim et al. [2000] J. Clin. Invest., 105, 191-198). The mechanism by which mannose supplementation corrects abnormal protein N-glycosylation in Man-P-Dol synthase deficient cells is unknown, but this observation suggests that the regulation of Man-P-Dol synthesis and utilization may be more complex than is currently understood.
AB - Congenital Disorders of Glycosylation (CDG) are human deficiencies in glycoprotein biosynthesis. Previous studies showed that 1 mM mannose corrects defective protein N-glycosylation in cultured fibroblasts from some CDG patients. We hypothesized that these CDG cells have limited GDP-mannose (GDP-Man) and that exogenous mannose increases the GDP-Man levels. Using a well established method to measure GDP-Man, we found that normal fibroblasts had an average of 23.5 pmol GDP-Man/106 cells, whereas phosphomannomutase (PMM)-deficient fibroblasts had only 2.3-2.7 pmol/106 cells. Adding 1 mM mannose to the culture medium increased the GDP-Man level in PMM-deficient cells to approximately 15.5 pmol/106 cells, but had no significant effect on GDP-Man levels in normal fibroblasts. Similarly, mannose supplementation increased GDP-Man from 4.6 pmol/106 cells to 24.6 pmol/106 cells in phosphomannose isomerase (PMI)-deficient fibroblasts. Based on the specific activity of the GDP-[3H]Man pool present in [2-3H]mannose labeled cells, mannose supplementation also partially corrected the impaired synthesis of mannosylphosphoryldolichol (Man-P-Dol) and Glc0-3Man9GlcNAc2-P-P-Dol. These results confirm directly that deficiencies in PMM and PMI result in lowered cellular GDP-Man levels that are corrected by the addition of mannose. In contrast to these results, GDP-Man levels in fibroblasts from a CDG-Ie patient, who is deficient in Man-P-Dol synthase, were normal and unaffected by mannose supplementation even though mannose addition was found to correct abnormal lipid intermediate synthesis in another study (Kim et al. [2000] J. Clin. Invest., 105, 191-198). The mechanism by which mannose supplementation corrects abnormal protein N-glycosylation in Man-P-Dol synthase deficient cells is unknown, but this observation suggests that the regulation of Man-P-Dol synthesis and utilization may be more complex than is currently understood.
KW - Congenital disorders of glycosylation (CDG)
KW - Fibroblast
KW - GDP-mannose
KW - Mannose
KW - Phosphomannose isomerase
UR - http://www.scopus.com/inward/record.url?scp=0033890977&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033890977&partnerID=8YFLogxK
U2 - 10.1093/glycob/10.8.829
DO - 10.1093/glycob/10.8.829
M3 - Article
C2 - 10929009
AN - SCOPUS:0033890977
SN - 0959-6658
VL - 10
SP - 829
EP - 835
JO - Glycobiology
JF - Glycobiology
IS - 8
ER -